Indications for cmyc inhibitors

Myc overexpression in breast cancer

MYC is overexpressed in over 40% of breast cancer patients and Myc gene amplification (increase in the number of Myc gene) is seen in about 15% of patients. Studies have confirmed the correlation between Myc amplification and poor prognosis. Worldwide, breast cancer is the most commonly-diagnosed type of cancer in women. In 2012, there were 1.6 million new cases and 500,000 deaths were reported, making it also the leading cause of cancer death.


Service 2

Mihi quidem Antiochum, quem audis, satis belle videris attendere. Hanc igitur quoque transfer in animum dirigentes.


Service 3

Tamen a proposito, inquam, aberramus. Non igitur potestis voluptate omnia dirigentes aut tueri aut retinere virtutem.